Efficacy and Safety of Darunavir/Ritonavir at 48 Weeks in Treatment-naïve, HIV-1–infected AdolescentsPatricia M. Flynn, Magda Opsomer, Stéphane Blanche et al.|The Pediatric Infectious Disease Journal|2014Cited by 28